Home / Sumatriptan / Norway
NO ATC N02CC01 · updated 2 Nov 2026
Sumatriptan shortage in Norway
Is there a Sumatriptan shortage in Norway?
Yes. As of 2 Nov 2026, 4 Sumatriptan products are reported short in Norway, the first since 3 Aug 2026. The company estimate for the return is 30 Nov 2026 (latest 8 Jan 2027). Main reason: manufacturing problem.
Also short in Canada, Germany, Italy, Spain, Ireland, Austria, Belgium, Czechia, Sweden, Japan, New Zealand, Australia. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Imigran 12 mg/ml injeksjonsvæske, oppløsning, 2x0,5 ml sylinderampulle til bruk i penn | Glaxosmithkline As | 3 Aug 2026 | 30 Nov 2026 | Manufacturing problem Produksjonsproblemer |
| NO | Sumatriptan Teva 50 mg tablett, filmdrasjert, 6 stk blisterpakning | Teva Sweden AB | 29 Sep 2026 | 11 Dec 2026 | Manufacturing problem Produksjonsproblemer |
| NO | Sumatriptan Teva 100 mg tablett, filmdrasjert, 6 stk blisterpakning | Teva Sweden AB | 19 Oct 2026 | 11 Dec 2026 | Manufacturing problem Produksjonsproblemer |
| NO | Sumatriptan Teva 100 mg tablett, filmdrasjert, 18 stk blisterpakning anticipated | Teva Sweden AB | 13 Nov 2026 | 8 Jan 2027 | Manufacturing problem Produksjonsproblemer |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).